Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy.

Ranganathan AC, Adam AP, Aguirre-Ghiso JA.

Cell Cycle. 2006 Aug;5(16):1799-807. Epub 2006 Aug 15. Review.

PMID:
16929185
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).

Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L.

Cancer Res. 2003 Apr 1;63(7):1684-95.

PMID:
12670923
[PubMed - indexed for MEDLINE]
Free Article
3.

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L.

Mol Biol Cell. 2001 Apr;12(4):863-79.

PMID:
11294892
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.

Aguirre Ghiso JA.

Oncogene. 2002 Apr 11;21(16):2513-24.

PMID:
11971186
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

[Tumor dormancy and identification of therapeutic targets].

Li CF, Cao S, Meng SD.

Ai Zheng. 2009 May;28(5):555-8. Review. Chinese.

PMID:
19624889
[PubMed - indexed for MEDLINE]
7.

ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.

Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA.

Clin Cancer Res. 2011 Sep 15;17(18):5850-7. doi: 10.1158/1078-0432.CCR-10-2574. Epub 2011 Jun 14. Review.

PMID:
21673068
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells?

Ranganathan AC, Adam AP, Zhang L, Aguirre-Ghiso JA.

Cancer Biol Ther. 2006 Jul;5(7):729-35. Epub 2006 Jul 1. Review.

PMID:
16861922
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.

Indraccolo S.

Adv Exp Med Biol. 2013;734:37-52. doi: 10.1007/978-1-4614-1445-2_3.

PMID:
23143974
[PubMed - indexed for MEDLINE]
10.

Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.

Xue A, Xue M, Jackson C, Smith RC.

Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1731-8. doi: 10.1016/j.biocel.2009.03.004. Epub 2009 Mar 21.

PMID:
19433314
[PubMed - indexed for MEDLINE]
11.

Tumor dormancy and cancer stem cells: two sides of the same coin?

Kleffel S, Schatton T.

Adv Exp Med Biol. 2013;734:145-79. doi: 10.1007/978-1-4614-1445-2_8.

PMID:
23143979
[PubMed - indexed for MEDLINE]
12.

Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells.

Yoshida C, Niiya K, Niiya M, Shibakura M, Asaumi N, Tanimoto M.

Blood Coagul Fibrinolysis. 2007 Jul;18(5):425-33.

PMID:
17581316
[PubMed - indexed for MEDLINE]
13.
14.

Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.

Ghosh S, Koblinski J, Johnson J, Liu Y, Ericsson A, Davis JW, Shi Z, Ravosa MJ, Crawford S, Frazier S, Stack MS.

Mol Cancer Res. 2010 Feb;8(2):145-58. doi: 10.1158/1541-7786.MCR-09-0045. Epub 2010 Feb 9.

PMID:
20145038
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.

Ly DP, Corbett SA.

J Surg Res. 2005 Feb;123(2):200-5.

PMID:
15680379
[PubMed - indexed for MEDLINE]
16.

The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?

Allgayer H, Aguirre-Ghiso JA.

APMIS. 2008 Jul-Aug;116(7-8):602-14. doi: 10.1111/j.1600-0463.2008.00997.x. Review.

PMID:
18834405
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.

Eur J Pharmacol. 2007 Jun 1;563(1-3):49-60. Epub 2007 Feb 8.

PMID:
17341418
[PubMed - indexed for MEDLINE]
18.

Tumor dormancy: long-term survival in a hostile environment.

Quesnel B.

Adv Exp Med Biol. 2013;734:181-200. doi: 10.1007/978-1-4614-1445-2_9.

PMID:
23143980
[PubMed - indexed for MEDLINE]
19.

Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.

Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.

Exp Mol Med. 2006 Feb 28;38(1):27-35.

PMID:
16520550
[PubMed - indexed for MEDLINE]
Free Article
20.

Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling.

Wang XQ, Sun P, Go L, Koti V, Fliman M, Paller AS.

J Invest Dermatol. 2006 Dec;126(12):2687-96. Epub 2006 Jul 6.

PMID:
16826166
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk